StonvexLoading…
StonvexStonvexStonvexCore line items from ANDE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.53B | $1.40B | $1.63B | $3.04B |
Operating Income | $141.47M | $200.76M | $169.56M | $194.58M |
Net Income | $95.71M | $114.01M | $101.19M | $131.08M |
EPS (Diluted) | $2.79 | $3.32 | $2.94 | $3.81 |
Total Assets | $3.71B | $4.12B | $3.86B | $4.61B |
Total Liabilities | $2.42B | $2.52B | $2.34B | $3.18B |
Cash & Equivalents | $98.28M | $561.77M | $643.85M | $115.27M |
Free Cash Flow OCF − CapEx | $-56.13M | $182.32M | $796.31M | $178.83M |
Shares Outstanding | 34.34M | 34.32M | 34.38M | 34.42M |